SomaLogic Acquisition Marks Next Step In Illumina's Advanced Biomarker Push

benzinga.com/m-a/25/06/46056588/somalogic-acquisition-worth-350-million-marks-next-step-in-illuminas-advanced-biomarker-push

On Monday, Illumina, Inc. (NASDAQ:ILMN) agreed to acquire Standard BioTools’ (NASDAQ:LAB) subsidiary, SomaLogic.
Following the announcement of the acquisition, Standard BioTools’ stock experienced a significant surge.
The deal consideration includes $350 million in cash payable at…

This story appeared on benzinga.com, 2025-06-23 16:04:58.
The Entire Business World on a Single Page. Free to Use →